Interaction between arrival time and thrombolytic treatment in determining early outcome of acute myocardial infarction

Heart

Volumn 88, Issue 6, 2002, Pages 583-586

  Wilkinson, J ^a   Foo, K ^a   Sekhri, N ^a   Cooper, J ^a   Suliman, A ^a   Ranjadayalan, K ^a   Timmis, Adam D ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHRONOLOGY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036898702     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.6.583     Document Type: Article

References (19)

1. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
2. Department of Health. National Service Framework for Coronary Heart Disease. London: Department of Health, 2000.
3. Volpi A, Maggioni A, Franzosi MG, et al. In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med 1987;317:257-61.
4. Behar S, Goldbourt U, Reicher-Reiss H, et al, and the principal investigators of the SPRINT study. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Am J Cardiol 1990;66:1208-11.
5. Sayer JW, Archbold RA, Wilkinson P, et al. Prognostic implications of ventricular fibrillation in acute myocardial infarction: New strategies required for further mortality reduction. Heart 2000;84:258-61.
6. French JK, Williams BF, Hart HH, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ 1996;312:1637-41.
7. Stevenson R, Ranjadayalan K, Wilkinson P, et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ 1993;307:349-53.
8. Birkhead JS, Norris R, Quinn T, et al, on behalf of the National Service Framework for Coronary Heart Disease Steering Group. Acute Myocardial Infarction: A Core Data Set. London: Royal College of Physicians, 1999.
9. Barakat K, Wilkinson P, Deaner A, et al. How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 1999;353:955-9.
10. Berger AK, Schulman KA, Gersh BJ, et al. Primary coronary angioplasty vs. thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA 1999;282:341-8.
11. Eagle KA, Goodman SG, Avezum A, et al, for the GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: Findings from the global registry of acute coronary events (GRACE). Lancet 2002;359:373-7.
12. Ottesen MM, Kober L, Jorgensen S, et al, on behalf of the TRACE study group. Consequences of overutilization and underutilization thrombolytic therapy in clinical practice. J Am Coll Cardiol 2001;37:1581-7.
13. Muller DW, Topol EJ. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med 1990;113:949-60.
14. European Secondary Prevention Study Group. Translation of clinical trials into practice: A European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996;347:1203-7.
15. Reikvam A, Ketley D. Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals. Int J Cardiol 1997;61:79-83.
16. Gitt AK, Senges J. The patient with acute myocardial infarction who does not receive reperfusion treatment. Heart 2001;86:243-5.
17. Brodie BR, Stuckey TD. Mechanical reperfusion therapy for acute myocardial infarction: Stent PAMI, ADMIRAL, CADILLAC and beyond. Heart 2002;87:191-2.
18. Bottiger BW, Bode C, Kem S, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial. Lancet 2001;357:1583-5.
19. Sleight P. Overutilization and underutilization of thrombolysis in routine clinical practice. J Am Coll Cardiol 2001;37:1588-9.